Fidelity Investments’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-744
Closed -$14K 5736
2022
Q1
$14K Buy
+744
New +$13.4K ﹤0.01% 4144

Other funds holding OCDX

Fidelity Investments's OCDX Position: Q2 2022 in Review

Fidelity Investments sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 744 shares — an estimated $14K sold.

Fidelity Investments first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $14K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Fidelity Investments reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Fidelity Investments sold 744 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $14K.
  • Fidelity Investments first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Fidelity Investments's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $14K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Fidelity Investments's 13F filing for Q2 2022, filed 12 Aug 2022.